| 产品描述: | Akt1/Akt2-IN-2 (compound 7) is an allosteric dual Akt1 and Akt2 inhibitor (IC50=138 nM and 212 nM, respectively). Akt1/Akt2-IN-2 increases activity of caspase-3, and inhibits viability of a number of tumor cells. |
| 体外研究: |
Akt1/Akt2-IN-2 (compound 7) 对 LnCaP,HT29,MCF7,A2780 细胞有细胞毒性。 Akt1/Akt2-IN-2 (2 μM, 4 μM) 分别在2 μM和4 μM时,诱导 LnCaP 细胞中 caspase-3 的活性增加 3 倍或 6.6 倍。 |
| 参考文献: |
1. Zhao Z, et al. Development of potent, allosteric dual Akt1 and Akt2 inhibitors with improved physical properties and cell activity. Bioorg Med Chem Lett. 2008 Jan 1;18(1):49-53.
|
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.529 ml |
7.647 ml |
15.295 ml |
| 5 mM |
0.306 ml |
1.529 ml |
3.059 ml |
| 10 mM |
0.153 ml |
0.765 ml |
1.529 ml |
| 50 mM |
0.031 ml |
0.153 ml |
0.306 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |